Cornovus Pharmaceuticals: Novel Treatment for Heart Failure
Despite the fact that heart failure is as common and deadly as cancer, there have been no new treatments introduced since the 1990s. Typical drugs include diuretics, ACE inhibitors, ARB, and beta-blockers, most of which are generic. As a result of the work of Dr. Bruce Liang of the UConn Health Center, agonism of the P2X4 receptor by MRS2339 showed outstanding cardio-protective effects in a variety of animal models of heart failure.
Cornovus Pharmaceuticals was formed under the umbrella of UConn… Show more
Created by eventbrite | Claim this event
|Check Site||Buy Now|
400 Farmington Ave.
Farmington, CT 06032